Archive - Latest News Search Engine - Global and Local Breaking News

Nasus Pharma Announces the Publication of Positive Clinical Results from its Phase 2 Study of FMXIN002 (NS002) Intranasal Epinephrine Powder

Nasus Pharma Announces the Publication of Positive Clinical Results from its Phase 2 Study of FMXIN002 (NS002) Intranasal Epinephrine Powder

GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation

GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation

Eramet to work with Gabon despite manganese exports ban

Eramet to work with Gabon despite manganese exports ban

Shein boosts product safety standards with 2.5m testing goal for 2025

Shein boosts product safety standards with 2.5m testing goal for 2025

Your briefing

Nasus Pharma Announces the Publication of Positive Clinical Results from its Phase 2 Study of FMXIN002 (NS002) Intranasal Epinephrine Powder

TEL AVIV, Israel, June 3, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused...

Nasus Pharma Announces the Publication of Positive Clinical Results from its Phase 2 Study of FMXIN002 (NS002) Intranasal Epinephrine Powder

GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation

Recognizing exceptional leadership in patient education and clinical skill in the GammaTile procedure TEMPE, Ariz., June 3, 2025 /PRNewswire/ -- GT Me...

GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation

Eramet to work with Gabon despite manganese exports ban

Eramet to work with Gabon despite manganese exports ban

Shein boosts product safety standards with 2.5m testing goal for 2025

Shein boosts product safety standards with 2.5m testing goal for 2025